Pfizer asks FDA to approve COVID-19 vaccine boosters to ages 5-11 – WISH-TV | Indianapolis News | Indiana Weather

NEW YORK (WISH) — Pfizer is seeking emergency use authorization from the U.S. Food and Drug Administration for a second COVID-19 booster dose for ages 5 to 11.

The pharmaceutical company says a study showed a third vaccine dose raised omicron-fighting antibodies by 36 times in this age group. A total of 140 children were included in the study.

The first two doses of Pfizer’s vaccine were authorized for kids age 5 to 11 in October.

Source link

Leave a Reply

Your email address will not be published.